9lione is a cloud-based pharmaceutical management system that offers OCR, GS-1 code reader, and customized lists for easy drug management.
9lione has raised $781K in total funding. The most recent round was Series A. The last funding was announced in September 2026.
9lione's investors include Incubate Fund, MITSUI SUMITOMO INSURANCE Venture Capital (MSIVC), DG VENTURES, Yokohama Capital, nano bank.
9lione is headquartered in Nerima, Japan.
9lione is a cloud-based pharmaceutical management system that offers OCR, GS-1 code reader, and customized lists for easy drug management.
9lione is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"9lione — Funding & Investors." VCBacked, September 11, 2026, https://www.vcbacked.co/company/9lione. Accessed October 1, 2026.
VCBacked. (2026). 9lione — Funding & Investors. Retrieved October 1, 2026, from https://www.vcbacked.co/company/9lione
{{cite web |title=9lione — Funding & Investors |url=https://www.vcbacked.co/company/9lione |website=VCBacked |access-date=October 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated